These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16364935)

  • 1. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels.
    Mangiafico RA; Sarnataro F; Mangiafico M; Fiore CE
    Age Ageing; 2006 Jan; 35(1):60-5. PubMed ID: 16364935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
    McDermott MM; Greenland P; Green D; Guralnik JM; Criqui MH; Liu K; Chan C; Pearce WH; Taylor L; Ridker PM; Schneider JR; Martin G; Rifai N; Quann M; Fornage M
    Circulation; 2003 Jul; 107(25):3191-8. PubMed ID: 12810614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
    Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
    Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic markers of inflammation and cognitive decline in old age.
    Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
    J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
    Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
    Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function.
    Wersching H; Duning T; Lohmann H; Mohammadi S; Stehling C; Fobker M; Conty M; Minnerup J; Ringelstein EB; Berger K; Deppe M; Knecht S
    Neurology; 2010 Mar; 74(13):1022-9. PubMed ID: 20350977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
    Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
    Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity C-reactive protein and cognitive function in older women.
    Weuve J; Ridker PM; Cook NR; Buring JE; Grodstein F
    Epidemiology; 2006 Mar; 17(2):183-9. PubMed ID: 16477259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study.
    Rafnsson SB; Deary IJ; Smith FB; Whiteman MC; Fowkes FG
    Psychosom Med; 2007 Jun; 69(5):425-34. PubMed ID: 17556639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
    McDermott MM; Ferrucci L; Liu K; Criqui MH; Greenland P; Green D; Guralnik JM; Ridker PM; Taylor LM; Rifai N; Tian L; Zheng J; Pearce WH; Schneider JR; Vonesh E
    J Am Geriatr Soc; 2005 Oct; 53(10):1688-96. PubMed ID: 16181167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.
    Werring DJ; Frazer DW; Coward LJ; Losseff NA; Watt H; Cipolotti L; Brown MM; Jäger HR
    Brain; 2004 Oct; 127(Pt 10):2265-75. PubMed ID: 15282216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke.
    Bernard TJ; Fenton LZ; Apkon SD; Boada R; Wilkening GN; Wilkinson CC; Soep JB; Miyamoto SD; Tripputi M; Armstrong-Wells J; Benke TA; Manco-Johnson MJ; Goldenberg NA
    J Pediatr; 2010 Apr; 156(4):651-6. PubMed ID: 20022340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
    Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and C-reactive protein are not markers of cognitive impairment in patients with major cardiovascular disease.
    Silbert B; Evered L; Scott DA; McCutcheon C; Jamrozik K
    Dement Geriatr Cogn Disord; 2008; 25(4):309-16. PubMed ID: 18311078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism.
    Coban E; Aydemir M
    Med Sci Monit; 2008 Jan; 14(1):CR42-46. PubMed ID: 18160944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.